<p>This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following:</p>
<p>— the identification of its materials of construction (medical device configuration);</p>
<p>— the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition);</p>
<p>— the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues);</p>
<p>— the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables);</p>
<p>— the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).</p>
<p>This document can also be used for chemical characterization (e.g. the identification and/or quantification) of degradation products. Information on other aspects of degradation assessment are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15.</p>
<p>The ISO 10993 series is applicable when the material or medical device has direct or indirect body contact (see ISO 10993-1 for categorization by nature of body contact).</p>
<p>This document is intended for suppliers of materials and manufacturers of medical devices, to support a biological evaluation.</p>
Registration number (WIID)
64750
Scope
<p>This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following:</p>
<p>— the identification of its materials of construction (medical device configuration);</p>
<p>— the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition);</p>
<p>— the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues);</p>
<p>— the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables);</p>
<p>— the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).</p>
<p>This document can also be used for chemical characterization (e.g. the identification and/or quantification) of degradation products. Information on other aspects of degradation assessment are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15.</p>
<p>The ISO 10993 series is applicable when the material or medical device has direct or indirect body contact (see ISO 10993-1 for categorization by nature of body contact).</p>
<p>This document is intended for suppliers of materials and manufacturers of medical devices, to support a biological evaluation.</p>
